Belgium· BE-AMP-SAM407556-00

Victrelis 200 mg

A protease inhibitors product containing boceprevir, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 2 of our 19 countries.

ATC J05AE

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVictrelis 200 mgATCJ05AEREGISTER NO.BE-AMP-SAM407556-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Boceprevir is registered in 2 of 19 countries.

Countries holding a registration under ATC J05AE (protease inhibitors), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose

Boceprevir · ATC J05AE

2 / 19 countries

  • Belgiumprice
  • Ireland
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Boceprevir
Manufacturer
Merck Sharp & Dohme
Country
Belgium (BE)
ATC code
J05AE
ATC class
Protease inhibitors
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2862282

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Boceprevir in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All boceprevir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6f204af8-149e-4d04-85a6-a716da36c189
GET /v1/drugs/6f204af8-149e-4d04-85a6-a716da36c189?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Victrelis 200 mg",
  "name_fr": "Victrelis 200 mg",
  "name_nl": "Victrelis 200 mg",
  "amp_code": "SAM407556-00",
  "strengths": [
    "200.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Boceprevir"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Protease Inhibitors",
  "authorisation_numbers": [
    "EU/1/11/704/002",
    "EU/1/11/704/001"
  ]
}

See everything about boceprevir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.